Outcome of treatment with pegylated interferon and ribavirin in heart transplant recipients with chronic hepatitis C

Transplantation Proceedings

Volumn 43, Issue 1, 2011, Pages 299-303

  Durante Mangoni, E ^a,b   Ragone, E ^a,b   Pinto, D ^a,b   Iossa, D ^a,b   Covino, F E ^b   Maiello, C ^b   Utili, R ^a,b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b AORN 'V Monaldi'   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; PEGINTERFERON ALPHA2B; RIBAVIRIN; TROPONIN I;

ADULT; AGED; ANEMIA; ANGINA PECTORIS; CASE REPORT; CLINICAL EXAMINATION; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; DEPRESSION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MONITORING; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ENDOCARDIAL BIOPSY; FEMALE; FLU LIKE SYNDROME; GENOTYPE; HEART ARRHYTHMIA; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HEMOLYSIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOMODULATION; MALE; PRIORITY JOURNAL; RECIPIENT; SCHEUER FIBROSIS SCORE; SCORING SYSTEM; THROMBOCYTOPENIA; TREATMENT DURATION; TREATMENT OUTCOME; VIRUS INHIBITION; VIRUS LOAD;

ADULT; AGED; ANTIVIRAL AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART TRANSPLANTATION; HUMANS; INTERFERONS; MALE; POLYETHYLENE GLYCOLS; RIBAVIRIN; VIRAL LOAD;

EID: 79951795482     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2010.09.096     Document Type: Conference Paper

References (21)

1. Gasink LB, Blumberg EA, Localio AR, et al: Hepatitis C virus seropositivity in organ donors and survival in heart transplant recipients. JAMA 296:1843, 2006
2. Pfau PR, Rho R, DeNofrio D, et al: Hepatitis C transmission and infection by orthotopic heart transplantation. J Heart Lung Transpl 19:350, 2000
3. File E, Mehra M, Nair S, et al: Allograft transmission of hepatitis C virus infection from infected donors in cardiac transplantation. Transplantation 76:1096, 2003
4. Haji SA, Starling RC, Avery RK, et al: Donor hepatitis-C seropositivity is an independent risk factor for the development of accelerated coronary vasculopathy and predicts outcome after cardiac transplantation. J Heart Lung Transplant 23:277, 2004
5. Lunel F, Cadranel JF, Rosenheim M, et al: Hepatitis virus infections in heart transplant recipients: epidemiology, natural history, characteristics, and impact on survival. Gastroenterology 119:1064, 2000
6. Gudmundsson GS, Malinowska K, Robinson JA, et al: Five-year follow-up of hepatitis C-naïve heart transplant recipients who received hepatitis C-positive donor hearts. Transplant Proc 35: 1536, 2003
7. Marelli D, Bresson J, Laks H, et al: Hepatitis C-positive donors in heart transplantation. Am J Transplant 2:443, 2002
8. Cano O, Almenar L, Martínez-Dolz L, et al: Course of patients with chronic hepatitis C virus infection undergoing heart transplantation. Transplant Proc 39:2353, 2007
9. Castella M, Tenderich G, Koerner MM, et al: Outcome of heart transplantation in patients previously infected with hepatitis C virus. J Heart Lung Transplant 20:595, 2001
10. Fagiuoli S, Minniti F, Pevere S, et al: HBV and HCV infections in heart transplant recipients. J Heart Lung Transplant 20:718, 2001
11. Bodziak KA, Hricik DE: New-onset diabetes mellitus after solid organ transplantation. Transpl Int 22:519, 2009
12. Burra P, Buda A, Livi U, et al: Occurrence of post-transplant lymphoproliferative disorders among over thousand adult recipients: any role for hepatitis C infection? Eur J Gastroenterol Hepatol 18:1065, 2006
13. Hoffmann CJ, Subramanian AK, Cameron AM, et al: Incidence and risk factors for hepatocellular carcinoma after solid organ transplantation. Transplantation 86:784, 2008
14. Fabrizi F, Bunnapradist S, Martin P: Treatment of hepatitis C in potential kidney and heart transplant patients. Clin Liver Dis 9:487, 2005
15. Wells JT, Lucey MR, Said A: Hepatitis C in transplant recipients of solid organs, other than liver. Clin Liver Dis 10:901, 2006
16. Fagiuoli S, Pevere S, Minniti F, et al: Natural leukocyte interferon alfa for the treatment of chronic viral hepatitis in heart transplant recipients. Transplantation 75:982, 2003
17. Hoofnagle JH, Seeff LB: Peginterferon and ribavirin for chronic hepatitis C. N Engl J Med 355:2444, 2006
18. Dienstag JL, McHutchison JG: American Gastroenterological Association technical review on the management of hepatitis C. Gastroenterology 130:231, 2006
19. Desmet VJ, Gerber M, Hoofnagle JH, et al: Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 19: 1513, 1994
20. Fagiuoli S, Cooper DK, Zuhdi N: Hepatitis C status of heart transplant recipients. Clin Transplant 12:5, 1998
21. Mawhorter SD, Avery RK: Can donors with prior hepatitis be safely used for heart transplantation? J Heart Lung Transplant 25:805, 2006